Stockreport

Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF SAN DIEGO, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel th [Read more]